Secteur Nuvectis Pharma, Inc.

Actions

NVCT

US67080T1088

Recherche biotechnologique et médicale

Temps réel estimé Cboe BZX 20:55:08 02/07/2026 Varia. 5j. Varia. 1 janv.
19,86 USD +1,77% Graphique intraday de Nuvectis Pharma, Inc. -28,83% +162,72%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+1,77%-28,83%+108,57%+162,37%+162,72%+163,76%+21,76% - - 518 M
+3,98%+5,55%+18,90%+27,50%+15,12%+76,40%+136,18%+214,48%+6 893,22% 56,21 Md
-3,12%+5,11%+21,31%+16,85%+33,83%+71,57%+94,67%-27,80% - 55,38 Md
+4,13%+8,29%+9,34%+6,89%+2,38%-9,97%-9,60%-56,49% - 23,75 Md
+2,43%+5,00%+5,75%-32,47%-36,97%+11,66%+428,65%+284,89%+972,28% 23,19 Md
+3,64%+10,54%+3,58%+2,87%+14,06%+39,81%-4,50%-74,80% - 18,14 Md
+4,11%+8,89%+21,33%+6,99%-7,55%+44,60%-27,73%-28,01%+52,36% 16,84 Md
+2,57%+20,26%+45,01%+119,69%+196,81%+181,98%+355,99%+1 677,35%+662,64% 15,86 Md
+1,80%+3,61%+13,62%+25,68%+25,83%+24,49%+188,29%+202,03%+585,09% 13,56 Md
+7,20%+10,70%+7,40%-5,92%+19,22%+42,91% - - - 12,97 Md
+1,62%+1,25%+14,87%-4,88%-10,67%+73,31%+130,40%+425,45% - 11,86 Md
+1,86%+7,25%+22,21%+29,87%+36,39%+152,21%+159,77%+320,48%+783,38% 11,58 Md
+2,47%+3,89%+16,28%+34,93%+24,04%+387,28%+133,95%+30,45%+1 433,52% 11,33 Md
+4,90%+6,14%+1,28%-22,34%-13,95%-33,47%+521,90%+94,19%+91,46% 11,16 Md
+7,67%+8,34%-18,21%-31,90%-16,11%+3,10%+168,18%+51,32% - 10,34 Md
+0,10%+0,12%+35,39%+17,31%+22,95%+53,63%+196,01% - - 9,76 Md
+1,85%+18,36%+27,52%+26,30%+365,66%+249,24%+236,50%-34,10% - 9,64 Md
+7,74%+16,18%+2,10%-27,49%+11,18%+47,02%+133,72%-32,39% - 9,21 Md
+2,30%+6,83%+20,96%-1,77%+24,28%+72,36%+16,53%+151,62% - 8,1 Md
-2,77%-3,19%+24,12%+80,41%+162,03%+453,81%+648,88%-51,16%-25,03% 7,72 Md
Moyenne +2,80%+4,59%+20,07%+21,54%+51,56%+105,29%+185,77%+185,15%+1 272,10% 16,86 Md
Moyenne pondérée par Capi. +2,34%+5,57%+16,32%+15,40%+33,81%+82,31%+164,48%+172,62%+2 720,05%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action NVCT
  4. Secteur Nuvectis Pharma, Inc.